Q&A

Clinical Trial Logistics Provider Of The Year: An Interview With Ariette Van Strien, President Of Marken

Marken-CEO Headshot C

Originally published in CEO Today Magazine.

While advanced therapies, mRNA vaccines, and novel treatments all have the potential to cure - not just treat - diseases which previously had few or no treatment options, these complex products require additional consideration for distribution and handling. Utilizing state-of-the-art GMP-compliant depot networks and logistics hubs is essential to maintain product quality and safety standards.

Marken’s comprehensive clinical storage and distribution services, direct-to-patient solutions, home healthcare options, kit productions, and biological sample shipments help customers overcome logistics challenges while optimizing costs and accelerating drug development in a world of continual disruption resulting in widespread shortages.

Read about Marken’s President, Ariette van Strien, who was named ‘Clinical Trial Logistics Provider of the Year’. Marken remains antifragile and at the forefront of logistics innovation, delivering novel treatments to patients globally. Through Ariette's leadership, Marken has increased patient-centric services coverage more than 300% since 2019.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader